COST-EFFECTIVENESS ANALYSIS OF PLUS ASPIRIN VS PLACEBO PLUS ASPIRIN IN THE TREATMENT OF ISCHEMIC STROKE BASED ON A RANDOMIZED CLINICAL TRIAL

被引：0
|
作者：
Xiang, Y. [1 ]
Fan, W. [2 ]
Zhou, L. [3 ]
Guo, Z. [3 ]
Zhou, N. [3 ]
Yang, N. [3 ]
Hu, M. [3 ]
机构：
[1] Sichuan Univ, Chengdu 51, Peoples R China
[2] West China Second Univ Hosp, Chengdu, Peoples R China
[3] Sichuan Univ, Chengdu, Peoples R China
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV21
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [11] Clopidogrel plus aspirin or aspirin alone for high risk patients with unstable angina: A cost-effectiveness analysis.
    Schleinitz, MD
    Heidenreigh, PA
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 166 - 166
  • [12] COST-EFFECTIVENESS ANALYSIS MODEL OF ASPIRIN AND ASPIRIN COMBINATION THERAPY IN ACUTE ISCHEMIC STROKE PATIENT IN WEST SUMATERA
    Fitria, N.
    Putrizeti, F.
    Sari, Y. O.
    VALUE IN HEALTH, 2022, 25 (07) : S366 - S366
  • [13] Cost-Effectiveness of Clopidogrel plus Aspirin versus Aspirin Alone for Secondary Prevention of Cardiovascular Events: Results from the CHARISMA Trial
    Chen, Jersey
    Bhatt, Deepak L.
    Dunn, Elizabeth Schneider
    Shi, Chunxue
    Caro, J. Jaime
    Mahoney, Elizabeth M.
    Gabriel, Sylvie
    Jackson, Joseph D.
    Topol, Eric J.
    Cohen, David J.
    VALUE IN HEALTH, 2009, 12 (06) : 872 - 879
  • [14] Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy
    Ferrara, Pietro
    Cortesi, Paolo A.
    Di Laura, Danilo
    Maggioni, Aldo P.
    Mantovani, Lorenzo G.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 459 - 468
  • [15] Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy
    Pietro Ferrara
    Paolo A. Cortesi
    Danilo Di Laura
    Aldo P. Maggioni
    Lorenzo G. Mantovani
    Clinical Drug Investigation, 2021, 41 : 459 - 468
  • [16] Aspirin plus clopidogrel versus aspirin Mono-Therapy for ischemic stroke
    Kumar, Ashish
    Shariff, Mariam
    Doshi, Rajkumar
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2020, 54 (01) : 69 - 69
  • [17] Cost-Effectiveness of Clopidogrel Plus Aspirin for Stroke Prevention in Patients With Atrial Fibrillation in Whom Warfarin Is Unsuitable
    Coleman, Craig I.
    Straznitskas, Andrew D.
    Sobieraj, Diana M.
    Kluger, Jeffrey
    Anglade, Moise W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (07): : 1020 - 1025
  • [18] Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial
    Navi, Babak B.
    Marshall, Randolph S.
    Bobrow, Dylan
    Singer, Samuel
    Stone, Jacqueline B.
    DeSancho, Maria T.
    DeAngelis, Lisa M.
    JAMA NEUROLOGY, 2018, 75 (03) : 379 - 381
  • [19] Ticagrelor Plus Aspirin Versus Aspirin Alone in Acute Ischemic Stroke or TIA - Analysis of Bleeding Events in the THALES Trial.
    Molina, Carlos
    Amarenco, Pierre
    Ladenvall, Per
    Aunes, Maria
    Denison, Hans
    Evans, Scott
    Himmelmann, Anders
    Jahreskog, Marianne
    James, Stefan
    Knutsson, Mikael
    Nylander, Sven
    Rother, Joachim
    Wang Yongjun
    Johnston, S. Claiborne
    STROKE, 2021, 52
  • [20] Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy
    Rawal, Shalin
    Sharma, Kamal
    Shah, Aditya
    Bavishi, Shriya
    Christian, Cleris
    Bhatt, Parjanya
    Konat, Ashwati
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345